Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New TNF-alpha inhibitors reported by Celgene

Sep. 13, 1996

Vasopressin antagonists from American Cyanamid

Sep. 13, 1996

Mitsui Toatsu claims long-acting oral form of MS-551

Sep. 13, 1996

Pharmacia & Upjohn discloses class III antiarrhythmic agents

Sep. 13, 1996

Antiarrhythmic peptides claimed by BASF

Sep. 13, 1996

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Inhibitors of ceramide-mediated signal transduction

Sep. 13, 1996

Researchers isolate sodium pump inhibitor from human placenta

Sep. 13, 1996

IVAX receives approval for generic antihypertensive drug

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...